Chief executive

Robert Ford

CHAIRMAN AND CEO · Abbott Laboratories

3 disclosed trades · 5 Feb 2025 to 25 Aug 2026 · latest filed 27 Aug 2026

Chief executive of Abbott Laboratories (ABT), tracked from the executive's own SEC Form 4 disclosures.

Recent disclosed trades

3 most recent of 3 trades. Amounts are shares times the reported price. Source: SEC Form 4 filings, filed to 27 Aug 2026.
CompanyTrade dateActionAmountFiled
Common shares without par value (ABT)2026-08-25Sell$46,204,7982026-08-27
Common shares without par value (ABT)2026-01-23Buy$2,013,9672026-01-26
Common shares without par value (ABT)2025-02-05Sell$37,435,2002025-02-07

Source: SEC Form 4 filings, trades from 5 Feb 2025 to 25 Aug 2026, latest filed 27 Aug 2026. Executives report their own trades on Form 4 within two business days.

Open the interactive profile: all trades, compare with others